Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 3/20 | 0.48 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | ELOVL6 | Q9H5J4 | 3/20 | 0.44 |
| ▸ | CCR6 | P51684 | 3/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | ENPP3 | O14638 | 4/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184976 | 0.88 | GCK (0.48) | GCKPPARGKEAP1NFE2L2 | |
| SCHEMBL184915 | 0.87 | PPARG (0.64) | GCKPPARGELOVL6CCR6PPARA | |
| SCHEMBL197390 | 0.86 | GCK (0.50) | GCKKEAP1NFE2L2 | |
| SCHEMBL184640 | 0.85 | GCK (0.50) | GCKPPARGELOVL6 | |
| SCHEMBL184498 | 0.84 | GCK (0.63) | GCKPPARGELOVL6KEAP1NFE2L2 | |
| SCHEMBL184906 | 0.84 | MMP13 (0.51) | GCKELOVL6KEAP1NFE2L2 | |
| SCHEMBL184731 | 0.84 | GCK (0.50) | GCKELOVL6KEAP1NFE2L2 | |
| SCHEMBL4249464 | 0.83 | PPARG (0.61) | PPARGPPARA | |
| SCHEMBL185010 | 0.82 | GCK (0.48) | GCKPPARGPPARA | |
| SCHEMBL184592 | 0.80 | GCK (0.51) | GCKPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402327-B1 | Acetamide compounds as glucokinase activators, their process and medicinal applications | IMPETIS BIOSCIENCES LTD (IN) | 2018-03-07 | — | — | EP | disclosed |
| EP-2402327-A1 | Acetamide compounds as glucokinase activators, their process and medicinal applications | Advinus Therapeutics Private Limited (IN) | 2012-01-04 | — | — | EP | disclosed |